title: Dasatinib-induced rapid regression and complete molecular remission of multiple subcutaneous tumours presenting as relapsed chronic myeloid leukaemia after cord blood transplantation.
authors.affiliation: Division of Haematology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya City, Hyogo, Japan.
authors.forename: Jun
authors.initials: J
authors.lastname: Nakata
authors.forename: Masaya
authors.initials: M
authors.lastname: Okada
authors.forename: Hiroya
authors.initials: H
authors.lastname: Tamaki
authors.forename: Atsushi
authors.initials: A
authors.lastname: Satake
authors.forename: Katsuji
authors.initials: K
authors.lastname: Kaida
authors.forename: Satoshi
authors.initials: S
authors.lastname: Yoshihara
authors.forename: Ruri
authors.initials: R
authors.lastname: Kato
authors.forename: Kazuhiro
authors.initials: K
authors.lastname: Ikegame
authors.forename: Hiroyasu
authors.initials: H
authors.lastname: Ogawa
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D036101:Cord Blood Stem Cell Transplantation / Q000009:adverse effects; D000069439:Dasatinib; D003937:Diagnosis, Differential; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000175:diagnosis* / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009378:Neoplasms, Multiple Primary / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D011743:Pyrimidines / Q000627:therapeutic use*; D012008:Recurrence; D012074:Remission Induction / Q000379:methods; D012878:Skin Neoplasms / Q000175:diagnosis* / Q000188:drug therapy* / Q000473:pathology; D013844:Thiazoles / Q000627:therapeutic use*; D047368:Tumor Burden / Q000187:drug effects
chemical_list: D000970:Antineoplastic Agents; D011743:Pyrimidines; D013844:Thiazoles; D000069439:Dasatinib